Monoclonal antibodies against Neisseria meningitidis lipopolysaccharide

22Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A cell line producing monoclonal antibodies directed against a lipopolysaccharide component of Neisseria meningitidis group A has been established. These antibodies reacted with only one of three lipopolysaccharide serotyping strains of group A meningococci by coagglutination, enzyme-linked immunosorbent assay, and Western blotting techniques. A Western blot analysis showed that a NaOH digest of lipopolysaccharide was detectable by the serotype-specific antibody. The monoclonal antibodies cross-reacted with a group B meningococcal strain in an enzyme-linked immunosorbent assay. The immunoblotting analysis also showed that these antibodies reacted with the lipopolysaccharides of a group B meningococcus as well as Haemophilus influenzae type B, but not with the lipopolysaccharides of several strains of Salmonella typhi, Escherichia coli, Streptococcus pneumoniae, and Neisseria gonorrhoeae.

Cite

CITATION STYLE

APA

Sugasawara, R. J., Prato, C., & Sippel, J. E. (1983). Monoclonal antibodies against Neisseria meningitidis lipopolysaccharide. Infection and Immunity, 42(3), 863–868. https://doi.org/10.1128/iai.42.3.863-868.1983

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free